Table 4 Results of explorative outcomes
Mean (SD) | Mean change (95% CI) | |||
|---|---|---|---|---|
Baseline vs 4 weeks | Baseline vs 8 weeks | 4 weeks vs 8 weeks | ||
FHSQ pain (0–100) | ||||
Baseline | 41.1 (12.7) | 15.8 (3.0 to 28.6) | 13.5 (− 0.3 to 27.2) | − 2.3 (− 12.2 to 7.6) |
4 weeks | 56.5 (26.6) | |||
8 weeks | 54.8 (28.2) | |||
FHSQ function (0–100) | ||||
Baseline | 61.9 (19.3) | 11.8 (− 0.1 to 23.7) | 12.9 (− 1.4 to 27.1) | 1.0 (− 9.8 to 11.9) |
4 weeks | 71.9 (24.8) | |||
8 weeks | 74.3 (26.0) | |||
FHSQ footwear (0–100) | ||||
Baseline | 35.8 (21.8) | 8.8 (− 5.0 to 22.6) | 12.0 (− 0.4 to 24.5) | 3.2 (− 2.6 to 9.1) |
4 weeks | 45.8 (29.0) | |||
8 weeks | 48.3 (27.6) | |||
FHSQ general foot health (0–100) | ||||
Baseline | 44.5 (21.0) | − 6.3 (− 21.3 to 8.8) | 9.0 (− 0.2 to 18.3) | 15.3 (2.4 to 28.2) |
4 weeks | 35.1 (27.5) | |||
8 weeks | 50.9 (26.6) | |||
PSEQ (0–60) | ||||
Baseline | 42.1 (8.9) | 5.2 (0.5 to 10.0) | 5.8 (0.2 to 11.3) | 0.6 (− 4.4 to 5.5) |
4 weeks | 47.0 (12.2) | |||
8 weeks | 48.2 (10.6) | |||
Plantar fascia thickness (mm) | ||||
Baseline | 5.6 (0.9) | 0.3 (− 0.1 to 0.7) | ||
8 weeks | 5.3 (1.2) | |||
Median (IQR) | Median change (95% CI) | |||
Baseline vs 4 weeks | Baseline vs 8 weeks | 4 weeks vs 8 weeks | ||
IPAQ walk (MET) | ||||
Baseline | 1155 (330–1732.5) | − 132 (− 251 to 231) | − 99 (− 921 to 317) | − 1155 (− 1598 to − 330) |
4 weeks | 1386 (198–2079) | |||
8 weeks | 495 (297–1386) | |||
IPAQ moderate (MET) | ||||
Baseline | 540 (300–2220) | 0 (− 1254 to 600) | 0 (− 480 to 480) | 600 (− 2104 to − 360) |
4 weeks | 720 (40–2880) | |||
8 weeks | 480 (240–960) | |||
IPAQ vigorous (MET) | ||||
Baseline | 440 (0–1520) | 0 (− 480 to 480) | 0 (− 73 to 313) | − 400 (− 1107 to 0) |
4 weeks | 240 (0–1440) | |||
8 weeks | 240 (0–960) | |||
IPAQ total (MET) | ||||
Baseline | 2475.5 (1391–4614) | 242 (− 922 to 2681) | − 171 (− 1592 to 864) | 423 (− 712 to 2084) |
4 weeks | 1935 (1200–6906) | |||
8 weeks | 2217 (1059–2772) | |||